Investor Presentation • Oct 22, 2018
Investor Presentation
Open in ViewerOpens in native device viewer
London - October 23rd - 24th , 2018
Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-lookingstatements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.
Hi-Tech industrial group active in opto-electronics with proprietary technologies and know how developed over 35 years
More than 20 companies active worldwide on several markets and application segments. Listed on the Milan Stock Exchange, Star segment since 2000
Progressively widening its worldwide presence registering continuous growth over the years
More than 40,000 laser sources sold and 5% of revenue invested in R&D
14% Revenue CAGR 2011 – 2017
35% EBIT CAGR 2011 – 2017
FY 2017 Consolidated Revenue: €306m, up 21% YoY
in Euro million
| \$ l l i i U S m o n |
2 0 1 4 |
2 0 1 6 |
2 0 2 1 |
C A G R |
C A G R |
|
|---|---|---|---|---|---|---|
| 1 4- 1 6 |
1 6- 2 1 |
|||||
| l b l d l l G i i i i o a n o n- n v a s v e a n m n m a y |
||||||
| d l h i i i i t t t t t n v a s v e m e c a a e s e c r e a m e n |
||||||
| t s y s e m s |
6. 9 3 2 |
8. 4 3 7 |
1 3. 9 9 2 |
1 0 % |
1 1 % |
|
| b d E t t t t n e r g y a s e r e a m e n s y s e m s - |
2. 0 3 3 |
2. 6 7 0 |
4. 3 8 0 |
1 5 % |
1 0 % |
|
| d h k h B i & S i i i t t o y s a p n g n g e n n g |
7 2 4 |
9 9 6 |
1. 9 6 5 |
1 7 % |
1 5 % |
|
| k S i j i t n r e u v e n a o n |
2 3 5 |
6 9 5 |
1. 0 8 9 |
1 % 5 |
9 % |
|
| l i H a r r e m o v a |
3 3 5 |
3 4 1 |
3 3 3 |
-2 % |
0 % |
|
| i L t t t e g e n r e a m e n s v |
3 1 1 |
1 5 7 |
8 1 7 |
9 % |
% 4 |
|
| d A i t c n e r e u c o n |
9 6 |
1 1 0 |
1 2 5 |
7 % |
3 % |
|
| l V i j i t a g n a r e u v e n a o n |
n a |
1 0 5 |
3 3 2 |
n a |
2 6 % |
|
| d l & l P i i t t t t g m e n e e s o n a o o r e m o v a |
8 0 |
9 9 |
1 4 2 |
1 1 % |
7 % |
|
| h O t e r |
1 2 6 |
1 6 7 |
2 0 7 |
1 5 % |
4 % |
|
| l T t o a |
2. 0 3 3 |
2. 6 0 7 |
4. 3 8 0 |
1 % 5 |
1 0 % |
Source: Medical Insight Report
Lasers increasingly adopted in high quality manufacturing for uniqueness, flexibility, environment friendliness, productivity
Jena
| '0 0 0 E r o u |
/ / 3 0 0 6 1 7 |
% | / / 3 0 0 6 8 1 |
% | % V a r. |
|---|---|---|---|---|---|
| d l M i e c a |
8 2 9 3 5 |
5 8 0 % , |
9 3 5 9 8 |
5 8 3 % , |
1 2 9 % , |
| d l i I t n s r a u |
9 9 2 5 4 |
2 0 % 4 , |
6 0 3 9 7 |
% 4 1, 7 |
8 % 1 1, |
| l T R t o a e e n e s v u |
1 4 2 8 7 7 |
% 1 0 0 0 , |
1 6 0 6 3 7 |
% 1 0 0 0 , |
% 1 2 4 , |
| G i r o s s m a r g n |
9 0 9 5 5 |
4 1, % 7 |
6 4 0 1 7 |
4 0 3 % , |
8 % 7 , |
| E B I T D A |
6 9 1 5 4 |
0 8 % 1 , |
3 9 1 5 4 |
9 6 % , |
0 8 % - , |
| E B I T |
1 3 1 3 4 |
% 9 2 , |
1 2 7 3 1 |
% 7 9 , |
% 3 1 - , |
| P I t r e a x n c o m e |
1 0 8 8 1 |
7 6 % , |
1 3 0 9 0 |
8 1 % , |
2 0 3 % , |
| i N t e n c o m e |
6 0 0 1 |
2 % 4 , |
2 7 4 5 |
6 % 4 , |
2 0 % 4 , |
| h N I t e n c o m e p e r s a r e |
0 3 1 , |
0 3 9 , |
| '0 E 0 0 u r o |
/ / 3 1 1 2 1 7 |
/ / 3 0 0 6 1 8 |
% V a r. |
|---|---|---|---|
| l T t t t o a n o n c r r e n a s s e s u |
6 6 6 5 4 |
2 0 7 7 4 |
0 8 % 1 , |
| k l N W i C i t t e o r n g a p a |
6 3 6 2 2 |
7 7 5 3 2 |
2 1, 9 % |
| f l i i i i N t t e n a n c a p o s o n |
8 0 6 4 5 |
6 9 6 5 7 |
2 2 1 % - , |
| l b l i i i i L t t o n e r m a e s g |
9 4 9 6 |
9 7 4 7 |
% 2 6 , |
| N E i t t e q u y |
2 0 4 2 9 6 |
2 0 6 3 2 2 |
% 1, 0 |
| l l d N i t t e c a p a e m p o y e |
1 1 9 7 9 0 |
1 4 0 5 2 5 |
1 7 3 % , |
| k l l i C i N W t t e o r n g a p a o n s a e s |
2 0 8 % , |
2 % 4 1 , |
|
| R O C E |
% 2 5 4 , |
% 1 8 1 , |
|
| / ( l l d ) E B I T N i t t e c a p a e m p o y e |
|||
| C a p e x |
5 0 6 0 |
9 6 6 4 |
| k h l 's h d i S E t t o c o e r q p e r s a r e u y |
9, 9 |
||
|---|---|---|---|
| / i k l d j. P B V A r c e o o a u e |
1, 9 |
||
| / ( ) 8 0 % E V E B I T E B I T |
1 3, 8 |
||
| / ( ) l l E V S 8 0 % S a e s a e s |
1, 1 |
||
| l. k E E M C t n. a r e a p. |
@ 3 5 9, 5 |
€ 1 8, 6 3 |
|
| f i i l i i N t t e n a n c a p o s o n |
@ 6 5, 8 |
/ / 3 0 0 6 1 8 |
|
| / l l i i i F t t t n a n c a n v e s m e n s m e r m |
2, 2 @ 1 |
/ / 3 0 0 6 8 1 |
|
| Am ou |
ln in m nts |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| h, Ju 3 0 2 0 1 8 t ne / d ica l he ic M Ae t t e s |
ice Pr |
Re ve nu e |
% Va r. Re v. |
E B I T |
% E B I T |
M K. Ca p. |
E V |
/ Sa les E V ( *) |
/ E V E B I T ( *) |
/ P E ( *) |
/ k P Bo o lue Va |
| Cu te ra |
\$ 2 2, 3 3 |
\$ 7 7 |
1 7 % |
\$ ( ) 7 |
-9 % |
\$ 3 0 9 |
\$ 2 8 0 |
1, 8 |
n.a | n.a | 4, 5 |
| io las B e |
\$ 1, 3 5 |
\$ 2 2 |
-6 % |
\$ ( ) 1 0 |
-4 4 % |
\$ 2 8 |
\$ 2 5 |
0, 6 |
n.a | n.a | 1, 4 |
| d S isr M ica am e |
\$ 0, 5 8 |
\$ 7 8 |
1 8 % |
\$ 1 4 |
1 8 % |
\$ 2 5 5 |
\$ 1 6 1 |
1, 0 |
5, 7 |
7, 2 |
0, 8 |
| Lu ic tro n |
€ 8, 7 1 |
€ 3 4 |
-1 % |
-€ 4 |
-1 2 % |
€ 2 1 6 |
€ 2 0 0 |
3, 0 |
n.a | n.a | 2, 2 |
| du ia l In tr s |
|||||||||||
| ho ics I P G P Co to n |
\$ 1 4 0, 3 8 |
\$ 7 7 3 |
1 8 % |
\$ 3 0 3 |
3 9 % |
\$ 7. 6 3 0 |
\$ 6. 5 0 8 |
4, 2 |
1 0, 7 |
1 4, 3 |
3, 5 |
| im du ie Pr In tr a s |
€ 2 5, 9 5 |
€ 2 1 7 |
% 7 |
€ 1 1 |
% 5 |
€ 2 7 2 |
€ 3 4 8 |
0, 8 |
1 6, 1 |
1 5, 7 |
1, 8 |
| 's Ha La n se r |
¥ 3 6, 1 7 |
¥ 5. 0 3 3 |
% -9 |
¥ 8 0 2 |
% 1 6 |
¥ 3 8. 6 0 0 |
¥ 3 6. 6 1 2 |
3, 6 |
2 2, 8 |
1 8, 0 |
4, 7 |
| ( ) l. E En 1 |
€ 8, 6 3 1 |
€ 6 1 1 |
2 % 1 |
€ 3 1 |
8 % |
€ 3 6 0 |
€ 2 8 2 |
1, 1 |
3, 8 1 |
8, 9 1 |
9 1, |
(1) EV and multiplies as for previous slide
(*) Revenue,Ebit and earnings annualized
Enrico ROMAGNOLI Investor Relations Managertel. +39 055-8826807E-mail: [email protected]
Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI [email protected] MARONGIU [email protected]. +39 06-69923324
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.